Financial News
Headline News about Merck & Co
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22263.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/03/biotech-stocks-2.jpg)
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
November 22, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/22/mrk.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/709790/a-pharmacist-serves-a-customer.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/growthstocks_1600_01.jpg)
![](https://www.investors.com/wp-content/uploads/2017/12/Stock-Biotech-13-Adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2021/03/Stock-gilead-07a-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/23/aapharma.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/22/cvm_logo_light__3eed6c94b257be872355c91a853aa9ed.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7882.png?width=1200&height=800&fit=crop)
What 13 Analyst Ratings Have To Say About Merck & Co
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/22/screenshot_2022-11-22_at_7.38.35_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/11/21/logo_light__cf5a9515433d3224f1809e9207e10fd6.png?width=1200&height=800&fit=crop)
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21865.jpeg?width=1200&height=800&fit=crop)
![](https://schaeffers-cdn.s3.amazonaws.com/images/default-source/schaeffers-cdn-images/2022/november/mmc/mmc-nov21.jpg?sfvrsn=1d40ad06_2)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21891.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/710246/tsla-semi.jpg)
![](https://investorplace.com/wp-content/uploads/2019/09/deal-handshake.jpg)
![](https://www.investors.com/wp-content/uploads/2017/10/stock-Merck-02-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/21/imgo_logo_light__f97c2266b34a1d4ab02ba8cb2862950f.png?width=1200&height=800&fit=crop)
Cancer-Focused Imago BioSciences Shares Soar After Merck Deal
November 21, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/20/jim_simons.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2017/08/retirementmsn8.jpg)
![](https://g.foolcdn.com/editorial/images/709702/investor-reviewing-a-stock-portfolio.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/11/18/merck_logo_horizontal_teal-grey_rgb.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2473.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_7880.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/17/gossamerbio-logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_21693.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.